Cardiovascular risk profile in pediatric CAH patients: a cross-sectional study

Cardiovascular risk profile in pediatric CAH patients: a cross-sectional study - Cardiovascular risk in CAH

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON38496

Enrollment

Registered

2013-11-13

Start date

2013-09-01

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital aderenal hyperplasia

Interventions

None listed

Eligibility

Age

2 Years to 17 Years

Inclusion criteria

Inclusion criteria: CAH due to 21-hydroxylase deficiency, biochemical and genetically proven Age: 1-16 years

Exclusion criteria

Exclusion criteria: CAH due to other enzym deficiency Refusal to participate by patient/parents Known co-morbidity: cardiac disease, renal disease, co-medication that interferes with blood pressure

Design outcomes

Primary

Measure	Time frame
Comparisson of the different cardiovascular riskfactors between CAH patients and reference values. - Insulin resistance - left ventricular hypertrophy - intima media thickness - body composition - 24-h systolic and diastolic bloodpressure - 24-h urinary steroid profile - circulating biochemical risk markers (e.g. lipids)	—

Secondary

Measure	Time frame
-	—

Countries

Netherlands

Outcome results